04Surgical · Urology
Disposable Circumcision Stapler
Cut and anastomose in a single pass.
Classification
Class II
NMPA Reg.
Lu Mech Reg. 20192020192
A single-use stapler that performs circumcision resection and anastomosis in one motion. Designed to shorten OR time, reduce bleeding and standardize the result across operators.
KEY FEATURES
What makes it work.
- One-pass cut + staple anastomosis
- Reduced bleeding and OR time
- Single-use, factory-sterilized
- Standardized stapler line for consistent outcomes
APPLICATIONS
Where it's used.
- Treatment of phimosis
- Treatment of redundant prepuce
SPECIFICATIONS
Technical specifications.
Classification
Class II medical device
NMPA registration
Lu Mech Reg. 20192020192
Sterilization
Factory EO sterilized
FROM VEMERIX INSIGHTS
Market analysis behind this product
Buyer Guide
When a Sample Lot Is Not the Commercial Lot: Why an ISO 11135:2014 Cycle File and FDA Rec 14-529 Do Not Adopt a New Size, Blister or Load, Why AAMI TIR28 Rec 14-603 Is the Product-Adoption Overlay, Why Annex E Single-Batch Release Is Not Adoption, and Why ISO/FDIS 11135 Is Not the Cycle File
An incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital buyers, and OEM engineers navigating ethylene-oxide cycle certificates, product adoption, single-batch release, and commercial pallet density across the US FDA, ISO, and AAMI frameworks in September 2026.
September 12, 2026 · 19 min read
Buyer Guide
When a Tender Demands 75 Percent or 80 Percent Remaining Shelf Life on a Sterile Device: Why FDA April 1991 and EU MDR GSPR 11.4 Do Not Set a Remaining-Percentage Statute, Why UNICEF October 2023 Uses Two Thirds and a Five-Year Floor, Why WHO TRS 1044 Annex 8 Is a Months Table After Risk Assessment, and Why ISO 11607 Is Not the Dock Clock
An operational procurement and regulatory guide for international medical-device distributors, hospital buyers, and OEM sellers navigating remaining-shelf-life tender clauses, incoming-inspection dock tests, and labelled expiration dates across the US, EU, UNICEF, and WHO frameworks in September 2026.
September 11, 2026 · 18 min read
Technical Guide
Which ISO 11607 Packaging Declaration of Conformity Survives 20 December 2026: Why FDA Rec 14-594 and 14-595 Name 2019 Including AMD1:2023, Why Rec 14-530 and 14-531 Remain Acceptable Until That Date, Why Decision (EU) 2024/815 Already Cites EN ISO 11607-1:2020/A1:2023, and Why GB/T 19633.1-2024 Is the 2019 IDT Implemented 1 December 2025
An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating sterile-barrier packaging validation files, declarations of conformity, and recognition timelines across the US, EU, and China in September 2026.
September 10, 2026 · 17 min read
Technical Guide
Which ISO 10993-7 Edition Governs an EO Residual CoA in 2026: Why ISO 10993-7:2026 Is Not FDA Recognition 2-275, Why the 25 May 2026 Part 1 Update Did Not Move Part 7, and Why MDCG 2024-13 Still Names EN ISO 10993-7:2008+A1:2022
An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating EO-sterilized single-use device residual certificates of analysis, dissipation curves, and regulatory recognition across the US, EU, and China in 2026.
September 9, 2026 · 16 min read
Buyer Guide
How to Qualify a Chinese Medical-Device Factory After NMPA Announcement 107: Why ISO 13485, MDSAP and a 2014 GMP Certificate Are Not the 1 November 2026 File, What Articles 2–3, 17–21, 32, 91, 104 and 107–113 Require, and Why a Production License or NMPA Registration Is Not China GMP
An operational factory-qualification and supplier-audit guide for international distributors, private-label/OEM buyers and hospital procurement teams evaluating Chinese sterile medical-device manufacturers under NMPA Announcement No. 107 of 2025, the 132-article Good Manufacturing Practice effective 1 November 2026, and the simultaneous repeal of CFDA Announcement No. 64 of 2014.
September 8, 2026 · 22 min read
Regulatory Guide
How to Place a Medical Device on the Mexican Market in 2026: Registro Sanitario versus 2010 FDA/Canada and 2012 Japan Equivalence Agreements versus Option F Abbreviated Pathway under the 18 July 2025 Lineamientos, IMDRF Management Committee versus MDSAP for GMP Certificates Only, Homoclave COFEPRIS-04-050 Still Physical, the 20 August 2026 Visor, Official LFD Article 195-A Fees, and Why CE / 510(k) / NMPA / MDSAP Do Not Replace a Mexican Sanitary Registration
An operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Mexican market under Ley General de Salud Articles 262 and 376, RIS Article 83 risk classes, the 2010 FDA/Canada and 2012 Japan equivalence agreements, and the 18 July 2025 Option F abbreviated pathway.
September 7, 2026 · 22 min read
Regulatory Guide
How to Place a Medical Device on the Japanese Market in 2026: Marketing Authorization Holder versus Designated MAH under PMD Act Articles 23-2 and 23-2-17, Foreign Manufacturer Registration under Article 23-2-4 versus Drug Accreditation, Todokede versus Ninsho versus Shonin, Ordinance 169 and MDSAP, Official Yen Fees, and Why CE / 510(k) / NMPA / HSA Do Not Replace a Japanese Licence
An operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Japanese market under PMD Act Articles 23-2, 23-2-4, and 23-2-17, MHLW Ordinance 169, and official PMDA user-fee schedules.
September 5, 2026 · 15 min read
Technical Guide
How to Review a Supplier's Production and Process-Control File After QMSR: Why 21 CFR 820.70, 820.75 and 820.80 Are Reserved, What ISO 13485 Clause 7.5 and 21 CFR 820.45 Require, What Compliance Program 7382.850 Inspects under Production and Service Provision, and Why a DHR Binder or Contract-Sterilizer Listing Is Not the File
A field-by-field file-review guide for medical device distributors, OEM buyers, and hospital procurement teams evaluating sterile single-use suppliers after 2 February 2026: why 21 CFR 820.70, 820.75, and 820.80 are reserved, what ISO 13485 Clause 7.5 and 21 CFR 820.45 mandate for production, process validation, and labeling inspection, and how FDA Compliance Program 7382.850 audits Production and Service Provision.
September 4, 2026 · 16 min read
Technical Guide
How to Review a Supplier's CAPA and Complaint File After QMSR: Why 21 CFR 820.100 and 820.198 Are Reserved, What ISO 13485 Clauses 8.2.2 / 8.3 / 8.5.2 / 8.5.3 and 21 CFR 820.35 Require, What Compliance Program 7382.850 Inspects, and Why an MDR Report Is Not the Complaint File
An incoming audit guide for medical device distributors, OEMs, and hospital procurement teams: why 21 CFR 820.100 and 820.198 are reserved under QMSR, how ISO 13485 Clauses 8.2.2, 8.3, 8.5.2, and 8.5.3 carry the legal duties, what 21 CFR 820.35 adds on top, what CP 7382.850 inspects under Measurement, Analysis, and Improvement, why an MDR report is not the complaint file, and a 7-point buyer acceptance protocol.
September 2, 2026 · 18 min read
Buyer Guide
Disposable Circumcision Device Manufacturers (2026): An Evidence-Verified Global Supplier Landscape for Distributors
A register-first supplier map that separates brands, legal manufacturers, sterilizers, listing establishments, certificate holders and distributors before an RFQ is issued.
August 31, 2026 · 76 min read
Technical Guide
How to Review a Supplier's Purchasing Controls and Outsourcing File After QMSR: Why 21 CFR 820.50 Is Reserved, What ISO 13485 Clauses 4.1.5 and 7.4 Require, What Compliance Program 7382.850 Inspects, and a Buyer Acceptance Checklist
A practical buyer's audit guide for medical device purchasing and outsourcing files: why 21 CFR 820.50 is reserved under QMSR, how ISO 13485 Clauses 4.1.5 and 7.4 carry the legal duties, what FDA Compliance Program 7382.850 inspects, why supplier-audit reports are no longer exempt, and a 7-point incoming acceptance checklist.
August 31, 2026 · 19 min read
Technical Guide
How to Review a Supplier's ISO 14971 Risk Management File: What QMSR Actually Requires After 2 February 2026, EN ISO 14971:2019+A11:2021 for MDR, China's GB/T 42062-2022, and a Buyer Acceptance Checklist
A practical buyer's audit guide for medical device risk management files: separating ISO 13485 QMSR process mandates from ISO 14971 conformity, verifying EN ISO 14971:2019+A11:2021 for EU MDR, navigating China's GB/T 42062-2022, and executing a 7-point incoming acceptance protocol.
August 27, 2026 · 18 min read
Regulatory Guide
How to Place a Medical Device on the Saudi Market in 2026: MDMA versus Authorized Representative versus Establishment License, SFDA Classes A–D, 2025 Fees, and the May 2026 Bundling Rules
An operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating the Kingdom of Saudi Arabia's MDMA requirements under Law M/54, the Technical File Assessment route, SFDA Classes A–D (MDS-G008), the May 2025 fee schedule, the 3 May 2026 bundling criteria (MDS-G028), Authorized Representative mandates, importer establishment licensing, and port-clearance verification.
August 25, 2026 · 18 min read
Technical Guide
How to Review a Supplier's ISO 10993 Biocompatibility File: Endpoints by Contact and Duration, the 2025 Edition Transition (FDA Deadline July 2029), and a US/EU/China Acceptance Checklist
A practical buyer's audit guide for medical device biological safety files: matching endpoints to contact category and duration, verifying test-article final form, navigating the ISO 10993-1:2025 transition across FDA, EU MDR and China NMPA, and spotting disqualifying file gaps.
August 22, 2026 · 18 min read
Regulatory Guide
How to Verify a Certificate of Free Sale for a Medical Device: A Distributor's Guide to CFS and Export Certificates, Checking Issuing Authorities (FDA, EU, UK MHRA, NMPA) and Spotting Red Flags
A practical field-by-field verification guide for medical device export certificates: authenticating FDA CFGs via FECV, validating EU MDR Article 60 certificates, checking UK MHRA free-sale documents, navigating China's May 2026 export certificate reforms, and matching scope to your RFQ.
August 21, 2026 · 19 min read
Regulatory Guide
How to Verify an ISO 13485 Certificate: A Distributor's Guide to Reading QMS Certificate Scope, Checking Certification-Body Accreditation, and Telling a Real Certificate From a Fake One
A practical field-by-field certificate reading guide, scope-to-SKU matching table, IAF CertSearch and accreditation-body verification workflow, 2026 Global ACI transition decoder, fake/mill certificate triage, and distribution agreement evidence schedule.
August 20, 2026 · 18 min read
Regulatory Guide
Registering and Distributing Disposable Circumcision Devices: A US (FDA 510(k)), EU (MDR) and China (NMPA) Market-Entry Evidence Pack for Distributors and Private-Label Buyers
A multi-jurisdiction regulatory matrix and distributor evidence checklist comparing US 21 CFR 884.4530, EU MDR Class IIa Rule 6, China provincial Class II NMPA registrations, and WHO prequalification gates.
August 17, 2026 · 19 min read
Buyer Guide
What the FDA MAUDE and Recall Record Reveals About Surgical Stapler Failures: A Post-Market Evidence Map for Surgical Stapler Procurement and Supplier Screening (2015–2026)
An original FDA post-market surveillance analysis of 3,645 MAUDE medical device reports, Class I/II recalls, and the 2021 Class II reclassification order (21 CFR 878.4740, product code GAG) translated into tender specifications, acceptance testing, and supplier-screening criteria for disposable surgical and circumcision stapler procurement.
August 13, 2026 · 16 min read
Buyer Guide
What the FDA MAUDE and Recall Record Reveals About Circumcision Device Failures: A Post-Market Evidence Map for Circumcision Procurement and Supplier Screening (2015–2026)
An original FDA surveillance analysis of 31 circumcision device 510(k) clearances, 34 recalls, and 942 MAUDE adverse-event reports (all-time; 592 in the 2015–2026 window) translated into tender acceptance criteria and supplier-vigilance questions for disposable circumcision stapler, ring, and clamp devices.
August 11, 2026 · 16 min read
Technical Guide
Disposable Circumcision Anastomat and Stapler: Device Mechanics, Sterile-Kit Components and Lot-Acceptance Tests for Procurement and Biomedical Engineering
A component-level technical guide to the single-use circumcision anastomat and stapler: the bell-and-staple firing mechanism, what belongs in the sterile convenience kit, the staple-formation and sterile-barrier lot-acceptance tests, and the US, EU and China classification — including why no US 510(k) predicate and no WHO prequalification exist for the stapler.
August 9, 2026 · 18 min read
Buyer Guide
Qualifying a Circumcision Device Manufacturer or Distributor Program: CE Evidence, QMS Scope, Legal-Manufacturer Role and Registration-Document Control
A practical audit and qualification checklist for distributors and private-label buyers evaluating circumcision device manufacturers, distinguishing ISO 13485 from product-specific CE certificates, defining legal-manufacturer obligations, and protecting territory exclusivity.
August 5, 2026 · 24 min read
Buyer Guide
Disposable Circumcision Device Bulk Price, MOQ and Landed Cost: A Quote-Normalization and Total-Cost Worksheet for Distributors and Bulk Buyers
A B2B procurement framework for turning ex-works device quotes into defensible landed-cost-per-unit figures, incorporating size-mix MOQ, sterile packaging, tariff treatment, customs classification, and lot-release terms.
August 5, 2026 · 22 min read
Buyer Guide
Disposable Circumcision Device Sizing and Portfolio Selection: A Distributor and Procurement Guide for Ring, Anastomat or Stapler and Kits (Adult versus Pediatric)
Matching device mechanics to clinical throughput, establishing adult and pediatric size ladders, and verifying FDA, CE, and NMPA registration evidence.
August 3, 2026 · 22 min read
Technical Guide
Ethylene Oxide Sterilization Validation for Single-Use Medical Devices: An ISO 11135 Process, ISO 10993-7 Residual and FDA Evidence Guide for OEM and Private-Label Buyers
Qualifying a sterile single-use device OEM demands a validated ISO 11135 process, documented ISO 10993-7 residual dissipation profiles below 4 mg EO / 9 mg ECH for limited contact, clear parametric or BI release protocols, and a regulatory change-control strategy under the FDA Sterilization Master File pilots.
August 3, 2026 · 16 min read
Buyer Guide
Medical Device Contract Manufacturing (2026): A Buyer's Evidence Checklist for Sterile Single-Use Devices
An ISO 13485 certificate is the opening question—not the answer.
August 3, 2026 · 24 min read
Technical Guide
Sterile Barrier Packaging and Shelf-Life Validation for Single-Use Medical Devices: An ISO 11607 and Accelerated-Aging Acceptance Guide
Passing ISO 11607 requires more than a cleanroom pouch—it demands a validated forming and sealing process under Part 2, Arrhenius accelerated-aging calculations under ASTM F1980 confirmed by real-time stability, transport simulation under ASTM D4169, and lot-release seal strength and integrity criteria.
August 3, 2026 · 16 min read
Regulatory Guide
Unique Device Identification (UDI) for Private-Label and OEM Single-Use Medical Devices: A US (FDA), EU (MDR/EUDAMED) and China (NMPA) Decision Matrix
Determining who holds the UDI-DI, which issuing agency to use, and when database submission becomes mandatory under 21 CFR 830, EU MDR Article 27, and NMPA UDI Rules.
August 3, 2026 · 22 min read
Market Analysis
From Scalpel-and-Suture to a Single Click: The Disposable Circumcision Device Shift
How single-use rings, circular staplers and disposable-suture kits turned a 20-minute scalpel-and-suture operation into a roughly 7-minute sutureless one — an Asia-led device shift the world adopted before the US FDA recorded it.
July 6, 2026 · 28 min read
MORE IN SURGICAL
Related products
Ready to evaluate Disposable Circumcision Stapler?
Sample units typically ship under 10 business days for qualified buyers. Distributors — ask about territory exclusivity.